Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 202-607-8 | CAS number: 97-77-8
Endpoint summary
Administrative data
Description of key information
Oral: LD50 rat = 500 mg/kg bw
Dermal (similar to OECD 402 limit test): LD50 rat: > 2000 mg/kg bw (both sexes)
Inhalation (similar to EPA-OPP 81-3): LC50 = 5.45 mg/L (both sexes, based on read-across)
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Dose descriptor:
- LD50
- Value:
- 500 mg/kg bw
Acute toxicity: via inhalation route
Endpoint conclusion
- Dose descriptor:
- LC50
- Value:
- 5 450 mg/m³ air
Additional information
Oral:
In an acute oral toxicity study performed similar to OECD Guideline 401, the LD50 was found to be greater than 5200 mg/kg for male rats and 4573 mg/kg for female rats (Branch, 1983b). The rats exhibited tremors, ataxia and lethargy.
In rabbits the oral LD50 for disulfiram was found to be 650 mg/kg bw when combined with administration of 1.5 g alcohol/kg bw 20 -24 hours after disulfiram administration (Barnes and Fox, 1955).
In a NIOSH publication from 1993, the acute oral LD50 in rats was reported to be 500 mg/kg bw (NIOSH, 1993).
Inhalation:
There were no data located with disulfiram on acute toxicity after inhalative exposure. However, there are reliable data on a surrogate substance. An acute inhalation study conducted with the read-across substance, thiram (CAS 137 -26 -8), gave an 4-h LC50 of 4.42 mg/L for both sexes (Holbert, 1987). After correction for the molecular weight difference between disulfiram and thiram (factor: 1.234), an LC50 of 5.45 mg/L for both sexes is to be assumed for disulfiram.
Dermal:
In GLP-compliant guideline study (limit test), 5 male and 5 female rabbits were dosed with 2000 mg/kg bw disulfiram under occlusive conditions (Branch, 1983a). The acute dermal LD50 value was > 2000 mg/kg bw, as no mortality was observed. The clinical signs were limited to erythema in 3 animals.
Justification for classification or non-classification
Based on the acute oral LD50 of 500 mg/kg bw in rats, the substance should be classified as harmful if swallowed Xn, R22 and Category 4, according to the EU Directive 67/548/EEC and the CLP Regulation, respectively.
The data on acute toxicity dermal and inhalative exposure are conclusive but not sufficient for classification according to the criteria of Directives 67/548/EEC (DSD) and 1272/2008/EC (CLP).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
